Lexaria Bioscience Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the Annual and Special Meeting of Shareholders held by Lexaria Corp. on June 17, 2011. The filing date is June 22, 2011. The company is incorporated in Nevada and headquartered in Vancouver, British Columbia, Canada.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events and shareholder voting results.
Material Changes
There are no material financial changes reported in this filing. The primary event is the successful ratification of corporate governance proposals by shareholders.
Management Commentary and Voting Results
Shareholders approved all proposals presented at the meeting. The results were as follows:
- Election of Directors: Chris Bunka, Bal Bhullar, and David DeMartini were elected for the ensuing year. Each nominee received 5,535,524 votes "For" (99.81%) and 10,725 votes "Against" (0.19%). No votes were withheld.
- Ratification of Auditors: Chang Lee LLP, Chartered Accountants, was appointed as the independent registered public accounting firm. The proposal received 6,314,288 votes "For" (99.2%), no votes "Against", and 50,613 abstentions (0.8%).
A news release detailing these results is included as Exhibit 99.1.
Investor Verification Checklist
- Verify the definitive proxy statement filed on May 13, 2011, for detailed background on the director nominees and auditor selection.
- Review the news release (Exhibit 99.1) for any additional commentary on the company's strategic direction not included in the 8-K text.
- Confirm the company's financial status in the most recent 10-K or 10-Q filings, as this 8-K contains no financial data.